Clinical Trial Update: A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, safety, and physiological effects of elinzanetant in participants with different kidney function; the trial is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms

Drugs mentioned

• Elinzanetant (elinzanetant)

Snippet

Sponsor: Bayer | Conditions: Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men | Phase 1 | Status: COMPLETED